Glassman Wealth Services’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-37
Closed -$428 1329
2023
Q4
$428 Buy
37
+2
+6% +$23 ﹤0.01% 1751
2023
Q3
$447 Hold
35
﹤0.01% 1761
2023
Q2
$480 Sell
35
-1
-3% -$14 ﹤0.01% 1647
2023
Q1
$552 Buy
36
+14
+64% +$214 ﹤0.01% 1596
2022
Q4
$295 Hold
22
﹤0.01% 1716
2022
Q3
$0 Sell
22
-25
-53% -$432 ﹤0.01% 1897
2022
Q2
$1K Buy
47
+3
+7% +$57 ﹤0.01% 1487
2022
Q1
$1K Buy
+44
New +$889 ﹤0.01% 1473
2020
Q3
Sell
-68
Closed -$2K 1452
2020
Q2
$2K Hold
68
﹤0.01% 880
2020
Q1
$2K Sell
68
-12
-15% -$293 ﹤0.01% 735
2019
Q4
$2K Buy
+80
New +$1.86K ﹤0.01% 778
2019
Q3
Sell
-41
Closed -$1K 1293
2019
Q2
$1K Buy
41
+7
+21% +$220 ﹤0.01% 904
2019
Q1
$1K Buy
+34
New +$1.06K ﹤0.01% 864

Other funds holding PAHC

Glassman Wealth Services's PAHC Position: Q1 2024 in Review

Glassman Wealth Services sold out of Phibro Animal Health (PAHC) in Q1 2024, closing a stake of 37 shares — an estimated $428 sold.

Glassman Wealth Services first reported a position in PAHC in Q1 2019 and held it in 13 quarters. The position peaked at $2K in Q2 2020. 138 funds tracked by Wall St. Rank hold PAHC as of Q1 2024.

  • Glassman Wealth Services reported no remaining Phibro Animal Health position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 37 Phibro Animal Health shares in Q1 2024, an estimated $428.
  • Glassman Wealth Services first reported a position in Phibro Animal Health in Q1 2019 and held it in 13 quarters.
  • Glassman Wealth Services's Phibro Animal Health position peaked at $2K in Q2 2020.
  • 138 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.